LLY

899.05

-1.36%↓

JNJ

239.58

-0.09%↓

ABBV

211.11

+2.32%↑

NVS

149.85

-0.59%↓

MRK

118.9

+0.13%↑

LLY

899.05

-1.36%↓

JNJ

239.58

-0.09%↓

ABBV

211.11

+2.32%↑

NVS

149.85

-0.59%↓

MRK

118.9

+0.13%↑

LLY

899.05

-1.36%↓

JNJ

239.58

-0.09%↓

ABBV

211.11

+2.32%↑

NVS

149.85

-0.59%↓

MRK

118.9

+0.13%↑

LLY

899.05

-1.36%↓

JNJ

239.58

-0.09%↓

ABBV

211.11

+2.32%↑

NVS

149.85

-0.59%↓

MRK

118.9

+0.13%↑

LLY

899.05

-1.36%↓

JNJ

239.58

-0.09%↓

ABBV

211.11

+2.32%↑

NVS

149.85

-0.59%↓

MRK

118.9

+0.13%↑

Home・Elenco Azioni・Vivani Medical

Vivani Medical

Aperta

1.06 -5.36

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.06

Massimo

1.12

Metriche Chiave
By Trading Economics
Entrata	614K -6.5M
Dipendenti	37

Dividendi
By Dow Jones
Utili prossimi	30 mar 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-25M 79M
Apertura precedente	6.42
Chiusura precedente	1.06

Vivani Medical Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

25 mar 2026, 20:20 UTC

Acquisizioni, Fusioni, Takeovers

Infosys Agrees to Acquire Stratus

25 mar 2026, 23:58 UTC

Utili

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

25 mar 2026, 23:58 UTC

Utili

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

25 mar 2026, 23:57 UTC

Utili

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

25 mar 2026, 23:57 UTC

Utili

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

25 mar 2026, 23:56 UTC

Utili

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

25 mar 2026, 23:56 UTC

Utili

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

25 mar 2026, 23:41 UTC

Discorsi di Mercato

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

25 mar 2026, 23:41 UTC

Utili

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

25 mar 2026, 23:34 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Gold Declines on Possible Technical Correction -- Market Talk

25 mar 2026, 22:08 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

25 mar 2026, 22:08 UTC

Discorsi di Mercato

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

25 mar 2026, 22:07 UTC

Utili

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

25 mar 2026, 22:07 UTC

Utili

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

25 mar 2026, 22:07 UTC

Utili

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

25 mar 2026, 22:07 UTC

Utili

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

25 mar 2026, 22:07 UTC

Utili

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

25 mar 2026, 21:58 UTC

Discorsi di Mercato

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

25 mar 2026, 21:37 UTC

Discorsi di Mercato

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

25 mar 2026, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

25 mar 2026, 21:13 UTC

Acquisizioni, Fusioni, Takeovers

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

25 mar 2026, 21:12 UTC

Acquisizioni, Fusioni, Takeovers

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

25 mar 2026, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

25 mar 2026, 20:50 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

25 mar 2026, 20:33 UTC

Acquisizioni, Fusioni, Takeovers

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

25 mar 2026, 20:31 UTC

Utili

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

25 mar 2026, 20:15 UTC

Acquisizioni, Fusioni, Takeovers

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

25 mar 2026, 20:15 UTC

Acquisizioni, Fusioni, Takeovers

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

25 mar 2026, 20:15 UTC

Acquisizioni, Fusioni, Takeovers

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

25 mar 2026, 20:15 UTC

Acquisizioni, Fusioni, Takeovers

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Confronto tra pari

Modifica del prezzo

Vivani Medical Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 0 che hanno fornito valutazioni azionarie a Vivani Medical - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Utile prima delle imposte

Vendite

Utile operativo

Chi Siamo Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.